Therapy Area Communications & Patient Advocacy Lead |
Barcelona Gran Vía |
España |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ene 14, 2025 |
Manager, US Reputation & Corporate Storytelling |
East Hanover |
Estados Unidos |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ene 10, 2025 |
Communication & Patient Advocacy Manager Greece |
Metamorfosis |
Grecia |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ene 09, 2025 |
Vice President of European Public Affairs |
Brussels |
Bélgica |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Ene 08, 2025 |
Communications & Patient Advocacy Manager |
Selangor |
Malasia |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Ene 07, 2025 |
Associate Director, R&D Executive Communications and Storytelling |
Cambridge (USA) |
Estados Unidos |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ene 03, 2025 |
Executive Director, Public Affairs (SERCE Czech Republic, Hungary, Poland, Russia, ECC) |
Basel (City) |
Suiza |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Dic 16, 2024 |
Director of Communications and Media Engagement for Finance and Strategy & Growth organizations |
Basel (City) |
Suiza |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Dic 16, 2024 |
Executive Director, Public Affairs WEC |
Basel (City) |
Suiza |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Dic 16, 2024 |
Head of Public Affairs, Ireland |
Dublin (Country President Office (CPO)) |
Irlanda |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Dic 12, 2024 |
Director, Emerging Policies Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Suiza |
People & Organization |
Corporate |
Communications & Public Affairs |
Dic 10, 2024 |
Country Head, Comms & Patient Advocacy |
Amsterdam |
Países Bajos |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Dic 09, 2024 |
Senior Manager, Owned Channel Strategy and Intelligence |
Toranomon (NPKK Head Office) |
Japón |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Dic 04, 2024 |
Associate Director, Patient Engagement, Neuroscience and Gene Therapies |
East Hanover |
Estados Unidos |
Development |
Innovative Medicines |
Communications & Public Affairs |
Dic 03, 2024 |
Therapy Area Communications & Patient Advocacy Manager |
Barcelona Gran Vía |
España |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Dic 03, 2024 |
Senior Manager Portfolio Advocacy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Suiza |
People & Organization |
Corporate |
Communications & Public Affairs |
Dic 02, 2024 |
Senior Manager Policy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Suiza |
People & Organization |
Corporate |
Communications & Public Affairs |
Dic 02, 2024 |
Head, Portfolio Policy |
East Hanover |
Estados Unidos |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Dic 02, 2024 |
Lead - Government Affairs |
Delhi (Office) |
India |
International |
Innovative Medicines |
Communications & Public Affairs |
Nov 26, 2024 |
Public Affairs Manager |
Ankara Gimat |
Turquía |
International |
Innovative Medicines |
Communications & Public Affairs |
Sep 13, 2024 |
Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Alemania |
International |
Innovative Medicines |
Communications & Public Affairs |
Jul 09, 2024 |